BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.35
+0.13 (1.41%)
At close: Apr 17, 2026, 4:00 PM EDT
9.54
+0.19 (2.03%)
After-hours: Apr 17, 2026, 5:34 PM EDT
BBOT Employees
BridgeBio Oncology Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 30 or 48.39% compared to the previous year.
Employees
92
Change
30
Growth
48.39%
Revenue / Employee
n/a
Profits / Employee
-$1,457,000
Market Cap
748.31M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 92 | 30 | 48.39% |
| Sep 30, 2025 | 81 | 19 | 30.65% |
| Mar 31, 2025 | 62 | - | - |
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| ARS Pharmaceuticals | 163 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| Alpha Tau Medical | 121 |
| Lexicon Pharmaceuticals | 81 |
| Design Therapeutics | 54 |
BBOT News
- 4 weeks ago - BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 6 weeks ago - BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor - GlobeNewsWire
- 6 weeks ago - BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 2 months ago - BBOT to Participate in Upcoming Investor Healthcare Conferences - GlobeNewsWire
- 2 months ago - BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs - GlobeNewsWire
- 4 months ago - BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire